Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Scientific Reports
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. scientific reports
  3. articles
  4. article
Identification and validation of NETs-associated biomarkers in osteoporosis with diabetes
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 18 March 2026

Identification and validation of NETs-associated biomarkers in osteoporosis with diabetes

  • Luyan Zhang1,
  • Liang Hao1,
  • Yu Wang1,
  • Yiqiong Shi1 &
  • …
  • Wenzhen Wei1 

Scientific Reports , Article number:  (2026) Cite this article

  • 1050 Accesses

  • Metrics details

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Biomarkers
  • Computational biology and bioinformatics
  • Diseases
  • Endocrinology
  • Immunology

Abstract

Osteoporosis and diabetes represent major global public health challenges. Neutrophil extracellular traps (NETs) serve as key components of the innate immune system by capturing and eliminating pathogens. This exploratory study aimed to preliminarily identify biomarkers associated with NETs in osteoporosis with diabetes and to provide initial insights into underlying molecular mechanisms. A transcriptomic sequencing dataset was integrated to analyze the molecular profiles of comorbid osteoporosis and diabetes (OP-DM). The NETs-related genes (NETs-RGs) were curated from previous literature. As a pilot investigation, biomarkers were identified through differential analysis, machine learning, and receiver operating characteristic (ROC). These candidate biomarkers were further evaluated by qRT-PCR and ELISA. Subsequently, molecular regulatory network construction, immune infiltration analysis, enrichment analysis, and drug prediction were conducted to generate hypotheses. S100A12 and SLC25A37 were identified as potential biomarkers. Their significant upregulation at the protein level (S100A12 and SLC25A37) was observed in an independent cohort. Enrichment analysis suggested that S100A12 was significantly enriched in 68 pathways, including “ECM-receptor interaction” and “maturity onset diabetes of the young”. SLC25A37 was significantly enriched in 54 pathways, primarily including “ribosome” and “Toll-like receptor signaling pathway”. A total of 7 immune cell types exhibited differences between the two groups. Furthermore, the XIST-hsa-miR-146a-5p-S100A12 and XIST-hsa-miR-7-5-SLC25A37 axes were suggested to have potential regulatory roles. Drugs such as rimegepant and eptinezumab were associated with biomarkers. This preliminary study suggests that S100A12 and SLC25A37 may serve as candidate biomarkers associated with NETs in osteoporosis with diabetes, providing a preliminary theoretical foundation for future larger-scale studies.

Similar content being viewed by others

Diabetes and its complications: molecular mechanisms, prevention and treatment

Article Open access 19 January 2026

Artificial intelligence–based diabetes risk prediction from longitudinal DXA bone measurements

Article Open access 16 July 2025

In-depth profile of biosignatures for T2DM cohort utilizing an integrated targeted LC-MS platform

Article Open access 04 March 2025

Data availability

The datasets generated and analyzed during the current study are available in the ArrayExpress repository under accession number E-MTAB-16559.

References

  1. Gupta, A. et al. Neutrophil Extracellular Traps Promote NLRP3 Inflammasome Activation and Glomerular Endothelial Dysfunction in Diabetic Kidney Disease. Nutrients 14 (14), 2965. https://doi.org/10.3390/nu14142965 (2022).

    Google Scholar 

  2. Ferrari, S. L. et al. Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos. Int. 29 (12), 2585–2596. https://doi.org/10.1007/s00198-018-4650-2 (2018).

    Google Scholar 

  3. Su, H. et al. Effect of Rhizoma Drynariae on differential gene expression in ovariectomized rats with osteoporosis based on transcriptome sequencing. Front. Endocrinol. (Lausanne). 13, 930912. https://doi.org/10.3389/fendo.2022.930912 (2022).

    Google Scholar 

  4. Leidig-Bruckner, G. & Ziegler, R. Diabetes mellitus a risk for osteoporosis? Exp. Clin. Endocrinol. Diabetes. 109 (Suppl 2), S493–S514. https://doi.org/10.1055/s-2001-18605 (2001).

    Google Scholar 

  5. Schwartz, A. V. Diabetes Mellitus: Does it Affect Bone? Calcif Tissue Int. 73 (6), 515–519. https://doi.org/10.1007/s00223-003-0023-7 (2003).

    Google Scholar 

  6. Chamberlain, J. J. et al. Treatment of Type 1 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes. Ann. Intern. Med. 167 (7), 493–498. https://doi.org/10.7326/M17-1259 (2017).

    Google Scholar 

  7. Zhuang, S. et al. Targeting P2RX1 alleviates renal ischemia/reperfusion injury by preserving mitochondrial dynamics. Pharmacol. Res. 170, 105712. https://doi.org/10.1016/j.phrs.2021.105712 (2021).

    Google Scholar 

  8. Lambert, S. et al. Neutrophil Extracellular Traps Induce Human Th17 Cells: Effect of Psoriasis-Associated TRAF3IP2 Genotype. J. Invest. Dermatol. 139 (6), 1245–1253. https://doi.org/10.1016/j.jid.2018.11.021 (2019).

    Google Scholar 

  9. Donkel, S. J. et al. Common and Rare Variants Genetic Association Analysis of Circulating Neutrophil Extracellular Traps. Front. Immunol. 12, 615527. https://doi.org/10.3389/fimmu.2021.615527 (2021).

    Google Scholar 

  10. Juha, M. et al. NETosis: an emerging therapeutic target in renal diseases. Front. Immunol. 14, 1253667. https://doi.org/10.3389/fimmu.2023.1253667 (2023).

    Google Scholar 

  11. Josefs, T. et al. Neutrophil extracellular traps promote macrophage inflammation and impair atherosclerosis resolution in diabetic mice. JCI Insight. 5 (7), e134796. https://doi.org/10.1172/jci.insight.134796 (2020).

    Google Scholar 

  12. Flores, R. et al. The Selective Estrogen Receptor Modulator Raloxifene Inhibits Neutrophil Extracellular Trap Formation. Front. Immunol. 7, 566. https://doi.org/10.3389/fimmu.2016.00566 (2016).

    Google Scholar 

  13. Zhang, Y. et al. A signature for pan-cancer prognosis based on neutrophil extracellular traps. J. Immunother Cancer. 10 (6), e004210. https://doi.org/10.1136/jitc-2021-004210 (2022).

    Google Scholar 

  14. Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672–D677. https://doi.org/10.1093/nar/gkae909 (2025).

    Google Scholar 

  15. Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27–30. https://doi.org/10.1093/nar/28.1.27 (2000). PMID: 10592173; PMCID: PMC102409.

    Google Scholar 

  16. Basaria, S. Link between diabetes and osteoporosis. Diabetes Care. 23 (4), 564–565. https://doi.org/10.2337/diacare.23.4.564 (2000).

    Google Scholar 

  17. Xia, P. et al. Roles of S100A8, S100A9 and S100A12 in infection, inflammation and immunity. Immunology 171 (3), 365–376. https://doi.org/10.1111/imm.13722 (2024).

    Google Scholar 

  18. Cao, S. et al. Identification of potential hub genes linked to immune and metabolic alterations in postoperative systemic inflammatory dysregulation. Front. Immunol. 14, 1238774. https://doi.org/10.3389/fimmu.2023.1238774 (2023).

    Google Scholar 

  19. Lei, S. S. et al. Epimedium brevicornum Maxim alleviates diabetes osteoporosis by regulating AGE-RAGE signaling pathway. Mol. Med. 31 (1), 101. https://doi.org/10.1186/s10020-025-01152-2 (2025).

    Google Scholar 

  20. Zhang, X. et al. S100A12 triggers NETosis to aggravate myocardial infarction injury via the Annexin A5-calcium axis. Nat. Commun. 16, 1746. https://doi.org/10.1038/s41467-025-56978-5 (2025).

    Google Scholar 

  21. Gellen, B. et al. Increased serum S100A12 levels are associated with higher risk of acute heart failure in patients with type 2 diabetes. ESC Heart Fail. 9 (6), 3909–3919. https://doi.org/10.1002/ehf2.14036 (2022).

    Google Scholar 

  22. Lill, R. Function and biogenesis of iron-sulphur proteins. Nature 460 (7257), 831–838. https://doi.org/10.1038/nature08301 (2009).

    Google Scholar 

  23. Chen, W. et al. Abcb10 physically interacts with mitoferrin-1 (Slc25a37) to enhance its stability and function in the erythroid mitochondria. Proc. Natl. Acad. Sci. U S A. 106 (38), 16263–16268. https://doi.org/10.1073/pnas.0904519106 (2009).

    Google Scholar 

  24. Visconte, V. et al. Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron. Leukemia 29 (1), 188–195. https://doi.org/10.1038/leu.2014.170 (2015).

    Google Scholar 

  25. Kang, R. et al. Mitochondrial quality control mediated by PINK1 and PRKN: links to iron metabolism and tumor immunity. Autophagy 15 (1), 172–173. https://doi.org/10.1080/15548627.2018.1526611 (2019).

    Google Scholar 

  26. Guo, M. et al. The cell fate regulator DACH1 modulates ferroptosis through affecting P53/SLC25A37 signaling in fibrotic disease. Hepatol. Commun. 8 (3), e0396. https://doi.org/10.1097/HC9.0000000000000396 (2024).

    Google Scholar 

  27. Wu, Y. et al. Characterizing mitochondrial features in osteoarthritis through integrative multi-omics and machine learning analysis. Front. Immunol. 15, 1414301. https://doi.org/10.3389/fimmu.2024.1414301 (2024).

    Google Scholar 

  28. Zhang, Y. S. et al. Advances in research on the relationship between mitochondrial dysfunction and osteoporosis: a bibliometric study from 2014 to 2024. Front. Med. (Lausanne). 12, 1597116. https://doi.org/10.3389/fmed.2025.1597116 (2025).

    Google Scholar 

  29. De Pascalis, C. & Etienne-Manneville, S. Single and collective cell migration: the mechanics of adhesions. Mol. Biol. Cell. 28 (14), 1833–1846. https://doi.org/10.1091/mbc.E17-03-0134 (2017).

    Google Scholar 

  30. Kanchanawong, P. & Calderwood, D. A. Organization, dynamics and mechanoregulation of integrin-mediated cell-ECM adhesions. Nat. Rev. Mol. Cell. Biol. 24 (2), 142–161. https://doi.org/10.1038/s41580-022-00531-5 (2023).

    Google Scholar 

  31. Takeda, K. & Akira, S. Toll-like receptors. Curr. Protoc. Immunol. Chap141421–Chap141423. https://doi.org/10.1002/0471142735.im1402s77 (2007).

  32. Chao, W. Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart. Am. J. Physiol. Heart Circ. Physiol. 296 (1), H1–H12. https://doi.org/10.1152/ajpheart.00995.2008 (2009).

    Google Scholar 

  33. Illien-Jünger, S. et al. AGEs induce ectopic endochondral ossification in intervertebral discs. Eur. Cell. Mater. 32, 257–270. https://doi.org/10.22203/eCM.v032a17 (2016).

    Google Scholar 

  34. Han, J. et al. Toll-like receptor 9 (TLR9) gene deletion-mediated fracture healing in type II osteoporosis with diabetes associates with inhibition of the nuclear factor-kappa B(NF-κB) signaling pathway. Bioengineered 13 (5), 13689–13702. https://doi.org/10.1080/21655979.2022.2063663 (2022).

    Google Scholar 

  35. Shen, X. et al. Suppression of TLR4 prevents diabetic bone loss by regulating FTO-mediated m6A modification. Int. Immunopharmacol. 122, 110510. https://doi.org/10.1016/j.intimp.2023.110510 (2023).

    Google Scholar 

  36. Manoj, H. et al. Cytokine signalling in formation of neutrophil extracellular traps: Implications for health and diseases. Cytokine Growth Factor. Rev. 81, 27–39. https://doi.org/10.1016/j.cytogfr.2024.12.001 (2025).

    Google Scholar 

  37. Elahi, R. et al. IL-17 in type II diabetes mellitus (T2DM) immunopathogenesis and complications; molecular approaches. Mol. Immunol. 171, 66–76. https://doi.org/10.1016/j.molimm.2024.03.009 (2024).

    Google Scholar 

  38. Lee, C. T. et al. White blood cell subtypes, insulin resistance and β-cell dysfunction in high-risk individuals–the PROMISE cohort. Clin. Endocrinol. (Oxf). 81 (4), 536–541. https://doi.org/10.1111/cen.12390 (2014).

    Google Scholar 

  39. Giovenzana, A. et al. Neutrophils and their role in the aetiopathogenesis of type 1 and type 2 diabetes. Diabetes Metab. Res. Rev. 38 (1), e3483. https://doi.org/10.1002/dmrr.3483 (2022).

    Google Scholar 

  40. Altamura, S. et al. The Evolving Role of Neutrophils and Neutrophil Extracellular Traps (NETs) in Obesity and Related Diseases: Recent Insights and Advances. Int. J. Mol. Sci. 25 (24), 13633. https://doi.org/10.3390/ijms252413633 (2024).

    Google Scholar 

  41. Fischer, V. & Haffner-Luntzer, M. Interaction between bone and immune cells: Implications for postmenopausal osteoporosis. Semin Cell. Dev. Biol. 123, 14–21. https://doi.org/10.1016/j.semcdb.2021.05.014 (2022).

    Google Scholar 

  42. Luo, Q. et al. Nanoparticle-microRNA-146a-5p polyplexes ameliorate diabetic peripheral neuropathy by modulating inflammation and apoptosis. Nanomedicine 17, 188–197. https://doi.org/10.1016/j.nano.2019.01.007 (2019).

    Google Scholar 

  43. Faraldi, M. et al. Plasma microRNA signature associated with skeletal muscle wasting in post-menopausal osteoporotic women. J. Cachexia Sarcopenia Muscle. 15 (2), 690–701. https://doi.org/10.1002/jcsm.13421 (2024).

    Google Scholar 

  44. Kern, F. et al. Validation of human microRNA target pathways enables evaluation of target prediction tools. Nucleic Acids Res. 49 (1), 127–144. https://doi.org/10.1093/nar/gkaa1161 (2021).

    Google Scholar 

  45. Tang, Z. et al. Inhibition of CRY2 by STAT3/miRNA-7-5p Promotes Osteoblast Differentiation through Upregulation of CLOCK/BMAL1/P300 Expression. Mol. Ther. Nucleic Acids. 19, 865–876. https://doi.org/10.1016/j.omtn.2019.12.020 (2020).

    Google Scholar 

  46. Matarese, A. et al. miR-7 Regulates GLP-1-Mediated Insulin Release by Targeting β-Arrestin 1. Cells 9 (7), 1621. https://doi.org/10.3390/cells9071621 (2020).

    Google Scholar 

  47. Zhan, C. et al. CGRP-Loaded ROS-Responsive Hydrogel Restores Neuro-Angiogenic Signaling to Promote Bone Regeneration in Diabetes-Associated Periodontitis. Adv. Sci. (Weinh). 12 (40), e06438. https://doi.org/10.1002/advs (2025).

    Google Scholar 

Download references

Acknowledgements

We thank Kanehisa Laboratories for providing permission (Ref: 254385) to use KEGG pathway images in this study.

Funding

This study was supported in part by Gansu Provincial People’s Hospital In-hospital Fund Program, Number: 25GSSYC-4; this study also was supported by grants from Gansu Provincial People’s Hospital In-hospital Fund Program, Number: 20GSSY4-19.

Author information

Authors and Affiliations

  1. Department of Geriatric Endocrinology, The People’s Hospital of Gansu Province, Yueguang, Asia-Pacific, Duanjiatan, East Section of Donggang Road, Chengguan District, Lanzhou, 730000, Gansu Province, China

    Luyan Zhang, Liang Hao, Yu Wang, Yiqiong Shi & Wenzhen Wei

Authors
  1. Luyan Zhang
    View author publications

    Search author on:PubMed Google Scholar

  2. Liang Hao
    View author publications

    Search author on:PubMed Google Scholar

  3. Yu Wang
    View author publications

    Search author on:PubMed Google Scholar

  4. Yiqiong Shi
    View author publications

    Search author on:PubMed Google Scholar

  5. Wenzhen Wei
    View author publications

    Search author on:PubMed Google Scholar

Contributions

LZ conceived and designed the study, managed project operations, and reviewed the final version of the manuscript, contributed significantly to manuscript writing, and implemented machine learning algorithms for data analysis. LH primarily responsible for the collection and analysis of specimens and patient data. YW conducted the literature review, provided experimental materials and technical support, and participated in discussions and revisions of the manuscript. YS participated in data analysis, reviewed and revised the manuscript, and contributed to figure preparation. WW interpreted patient data. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Luyan Zhang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

The experimental protocol was established, according to the ethical guidelines of the Helsinki Declaration and was approved by the Human Ethics Committee of the People’s Hospital of Gansu Province, the number was 2023 − 299.Written informed consent was obtained from each participant before data collection.

Informed consent

Written informed consent has been obtained from the patients to publish this paper.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Material 1 (download PDF )

Supplementary Material 2 (download DOCX )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, L., Hao, L., Wang, Y. et al. Identification and validation of NETs-associated biomarkers in osteoporosis with diabetes. Sci Rep (2026). https://doi.org/10.1038/s41598-026-44721-z

Download citation

  • Received: 04 December 2025

  • Accepted: 13 March 2026

  • Published: 18 March 2026

  • DOI: https://doi.org/10.1038/s41598-026-44721-z

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Osteoporosis with diabetes
  • Neutrophil extracellular traps
  • Machine learning
  • Biomarkers
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • About Scientific Reports
  • Contact
  • Journal policies
  • Guide to referees
  • Calls for Papers
  • Editor's Choice
  • Journal highlights
  • Open Access Fees and Funding

Publish with us

  • For authors
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Scientific Reports (Sci Rep)

ISSN 2045-2322 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research